Resilience19 wrote: @yeehaw, agreed. However, my take is that frustration stems from unmet expectations. Granted many here have been repeatedly disappointed by the way mamangement has played DM over the past months (Ryu selling, little to no tangible updates on the likes of AI, OTCQB, Ronin etc).
However, DM has been managed as sorts for the past years, going from crypto/blockhchain, to AI to COVID to Telemed to drones... As such, although several of these have significant upside potential, I think it's useful to manage expectations as though they were waypoints on a trip, where direction may change, as long as the aim is maintained.
For my part, the greater scheme of things is to make money. How we get there is almost irrelevant, insofar as I can keep the conviction that we're on the right track to meeting my objective, irrespective of the route taken. At this time in point, in my opinion, the lowest laying fruit stems from income generated from COVID-19 tests. If another vertical further reinforces this (i.e. a good chunk of an MDA co-bid contract etc), that can act as a further catalyst to take the sp, say from $1 (C-19 tests) to $1.50 (MDA) to 2.00 (Ronin spin-off) to 2.50 (GBLC price increase) to $3 (telehealth etc)...so much the better. But I'll assess this in time, as management delivers or not, against other opportunities in the market.
I hold a strong position in DM and intend to keep a decent core position for some time BUT will measure my holding against my overall objective - I won't hold DM for years if I feel management does not deliver.
In short, although I also am not overly impressed with the way management has addressed issues (i.e. Ryu, PRs etc), I'm happy that they were able to be opportunistic with regards to COVID, if it's to generate significant income and sp valuation. I'm somewhat concerned that they're increasingly going all over the place (lack of strategic focus) and will, accordingly, measure my investment (i.e. if they don't deliver I'll reallocate part of my position elsewhere).
However, a LOT is in the pipeline over the coming quarters, so I give manangement the benefit of the doubt. We're a stone's through away from getting more clarity through the upcoming Q4 and Q1. If they deliver I'll remain strong. If they only partially meet expectation, I'll adjust my position accordingly - keeping the option of returning at a later date, if needed.
Staying zen.
Yeehaw1 wrote: BTC is gamble we all know that
but DM must take advantage to further improve their balance sheet as they took advantage of test kits
DM management must be thinking about this but when the plan of action they will take who knows
that is creating frustration ... at least they should make the shareholders aware of something
and as far as price is concerned we if RYU had not crush the momentum then we would have cross 40 at atleast
Resilience19 wrote: Impressive, as BTC's proce has gone from $6900 a year ago to $63000 today, representing roughly a 9x increase. This said, during that same period DM went from 0.04 to a recent high of 0.37, also a roughly 9x increase.
My take is that DM could be around 1.00 by end-May, or 2.7x its recent high of 0.37.
In order to perform equally as strong BTC would need to ride to $170,000.
Possible, but my gamble is on DM reaching 1.00 before BTC reaches 170,000...
Yeehaw1 wrote: 63,355.70 United States Dollar